Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde(Hertie Institute for Clinical Brain Research), Mathias Jucker(University of Basel), Michael E. Calhoun(Hertie Institute for Clinical Brain Research), Janaky Coomaraswamy(Hertie Institute for Clinical Brain Research), Stephan A. Kaeser(Hertie Institute for Clinical Brain Research), Bernardino Ghetti(Indiana University School of Medicine), Tristan Bolmont(Hertie Institute for Clinical Brain Research), Paul M. Mathews(Nathan Kline Institute for Psychiatric Research), Christian Czech(Pfizer (United States)), Christian Haass(German Center for Neurodegenerative Diseases), Dennis Lindau(Hertie Institute for Clinical Brain Research), Simon Gengler(University of Ulster), Christian Hölscher(Shanxi Medical University), Fabienne Jäggi(University of Basel), Hartwig Wolburg(University of Tübingen), Lars Stoltze(University of Tübingen)
Cited by 1,009
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Cryo-EM structures of tau filaments from Alzheimer’s disease
|Nature|2017|2.1k
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
|Proceedings of the National Academy of Sciences|1998|1.5k
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
|Annals of Neurology|1999|1.4k